Efficacy and safety of polyethylene glycol loxenatide in type 2 diabetic patients: a systematic review and meta-analysis of randomized controlled trials

Polyethylene glycol loxenatide (PEX168) is a novel glucagon-like peptide-1 receptor agonist with a longer half-life developed by modifying the chemical structure of exenatide. This study aims to assess the efficacy and safety of PEX168 and determine the best dose. We searched PubMed, Scopus, Cochran...

Descripción completa

Detalles Bibliográficos
Autores principales: Salamah, Hazem Mohamed, Marey, Ahmed, Elsayed, Esraa, Hasan, Mohammed Tarek, Mahmoud, Abdelrahman, Abualkhair, Khaled Alsayed, Abo-elnour, Dina Essam, Abdelhaleem, Ibrahim Abdelmonaem, Abd-Elgawad, Mohamed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10624877/
https://www.ncbi.nlm.nih.gov/pubmed/37923756
http://dx.doi.org/10.1038/s41598-023-46274-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10624877/
https://www.ncbi.nlm.nih.gov/pubmed/37923756
http://dx.doi.org/10.1038/s41598-023-46274-x

Ejemplares similares